Hainan Haiyao Co., Ltd. (SHE:000566)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Traditional Chinese Medicinal Materials Wareshouding and Trading	57.41M	-	-	-	-
Sale and Manufacturing of Active Pharmaceutical Ingredients	166.79M	-	-	-	-
Others	214.76M	-	-	-	-
Manufacturing and Sale of Medicine Preparation	443.52M	-	-	-	-
Intersegment Elimination	-62.96M	-	-	-	-
Total	819.52M	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	764.59M	930.91M	1.44B	1.68B	1.98B
Foreign	66.59M	59.79M	36.20M	102.24M	74.53M
Total	831.18M	990.70M	1.48B	1.78B	2.06B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error